Services at Sypharma

Sypharma offers world leading full molecule-to-market manufacturing and scale-up support, throughout all phases from pre-clinical development through to commercialisation.

Our Services Cover

Clinical Trial Manufacture

From Pre-Clinical to Phase 3, we follow the journey of your molecule.

Automation

The integration of sophisticated automated robotic systems stands as a cornerstone of our commitment to excellence in production.

Superheated Water

Incorporating a superheated water autoclave ensures an unparalleled level of sterilisation for intravenous fluid production.

Custom Needs

Beyond standard solutions, we offer tailored products that are unique to your process.

Custom Solutions

We work closely with our clients to understand their unique requirements and develop tailored solutions.

Custom Designs

Customized packaging options, including single-use bioprocess containers and intermediate bulk containers (IBCs).

Aseptic Fill & Finish

Your Journey to Commercialization

Our services range from Proof-of-Concept to small-scale manufacturing for preclinical purposes (prototypes/toxicity studies), progressing through various stages of clinical supply (Phase I/II/III), and culminating in commercial manufacturing (listed/registered) of Small Volume Parenteral products (including small molecules, large molecules, and biologics) as well as Medical Devices.

Terminal
Sterilization

Pioneering Excellence in Automated Manufacturing

Located in Dandenong Victoria, Sypharma has one of the largest intravenous fluid manufacturing facilities in Australia and New Zealand.

Automation

At Sypharma, the integration of sophisticated automated robotic systems stands as a cornerstone of our commitment to excellence in production. By reducing reliance on manual handling, these robotics solutions effectively minimize the potential for contamination, safeguarding the integrity of your products. In essence, our embrace of robotic automation represents a testament to our unwavering pursuit of quality, efficiency, and workplace safety.

Superheated Water

Incorporating a superheated water autoclave into its manufacturing process, Sypharma ensures an unparalleled level of sterilisation for its intravenous fluid production. This innovative approach not only accelerates the sterilization process but also minimizes environmental impact by avoiding the need for chemical additives or emissions associated with steam generation.

Custom Buffer
& CIP Solutions

Tailored to Your Specialized Needs

Buffer solutions are used in various processes such as pH adjustment, stabilization of reaction conditions, and dilution of samples. These solutions are customized to precise specifications to ensure optimal performance in specific applications.

Custom Solutions

We work closely with our clients to understand their unique requirements and develop tailored solutions. Additionally, we provide technical support and assistance in implementing these solutions to ensure optimal performance and efficiency.

We go beyond standard solutions to offer customized packaging options, including single-use bioprocess containers and intermediate bulk containers (IBCs). These specialized packaging solutions are designed to meet the unique needs of pharmaceutical and biopharmaceutical manufacturers.

Sykes Vet International

Established primarily as a brand for farming livestock, the company’s range includes long trusted medications and ointments.

Sykes was first established in 1880 and had offices in Australia and New Zealand by the early 1900s.

Today Sykes Vet International is proudly owned by Sypharma Australia and produces a broad range of animal health products for cattle, sheep, pigs, poultry, horses, cats, dogs and other animals.

Our dedication to quality is uncompromising.

And it covers every stage of everything we do. From development, clinical testing, and production through to commercialisation. Hundreds of organisations around the world trust Sypharma to fast track drug development through every stage of research, development, quality, safety and commercialisation.

Unlocking resources

Collaboration & Potential

We work together with innovative biotech developers to your drug production destination means the world to us, and our dedicated team of experts will support and guide you from the earliest stage of development through commercialization and beyond.


  • Clinical Development of SpikoGen®

    An Advax-CpG55.2 adjuvanted recombinant spike protein vaccine.

    Read Fact Sheet
  • Ensuring Efficacy and Safety

    The Critical Role of Pharmaceutical Cold Chain Transportation

    Read Fact Sheet
  • University of Queensland partners with Sypharma

    Sypharma partners with The University of Queensland for the manufacture of their CoVID-19 Vaccine Product.

    Read Press Release
  • Technovalia, Sypharma and BioNet announce the establishment of Genetis

    Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines.

    Read Press Release

Since 2005 unlocking healthier futures.